AMYLIN OHIO LLC | AstraZeneca | Ohio | state | 2013 | $150,000 | | grant |
Dr. Reddy's Laboratories Tennessee, LLC | Dr. Reddy's Laboratories | Tennessee | state | 2013 | $312,500 | | training reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Albany Molecular Research, Inc. | Curia Inc. | Indiana | state | 2013 | $350,000 | | tax credit/rebate |
Eli Lilly dba Elanco Animal Health | Eli Lilly | Indiana | state | 2013 | $500,000 | | grant |
Immunex Rhode Island Corp. | Amgen | Rhode Island | state | 2013 | $258,315 | | tax credit/rebate |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $7,800 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $7,293 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $7,200 | | cost reimbursement |
Novitas Solutions, Inc. | Novartis | Florida | state | 2013 | $500,000 | | tax credit/rebate |
Actavis, Inc. | AbbVie | Florida | state | 2013 | $690,000 | | grant |
Novitas Solutions, Inc. | Novartis | Florida | state | 2013 | $1,200,000 | | tax credit/rebate |
McNeil Consumer Healthcare Division of McNEll-PPC, | Johnson & Johnson | Illinois | state | 2013 | $105,502 | | tax credit/rebate |
IDEXX DISTRIBUTION INC | IDEXX Laboratories | Maine | state | 2013 | $1,515 | | property tax abatement |
IDEXX PHARMACEUTICALS INC | IDEXX Laboratories | Maine | state | 2013 | $2,613 | | property tax abatement |
ALERE SCARBOROUGH, INC. | Abbott Laboratories | Maine | state | 2013 | $18,018 | | property tax abatement |
IDEXX LAB INC | IDEXX Laboratories | Maine | state | 2013 | $64,733 | | property tax abatement |
IDEXX OPERATIONS INC | IDEXX Laboratories | Maine | state | 2013 | $75,901 | | property tax abatement |
Alexion Pharmaceuticals, Inc | AstraZeneca | Connecticut | state | 2013 | $26,000,000 | | grant/loan hybrid program |
Durata Therapeutics, Inc. | AbbVie | Connecticut | state | 2013 | $2,250,000 | | grant/loan hybrid program |
APTALIS PHARMATECH INC | AbbVie | Ohio | state | 2013 | $25,390 | | training reimbursement |
Genentech Inc | Roche | Oregon | state | 2013 | $3,340,842 | | tax credit/rebate |
Genentech | Roche | Oregon | state | 2013 | $227,332 | | property tax abatement |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2013 | $100,000 | | tax credit/rebate |
Alexion Pharmaceuticals | AstraZeneca | Rhode Island | state | 2013 | undisclosed | | tax credit/rebate |
Pfizer, Inc. | Pfizer | Tennessee | local | 2013 | undisclosed | | property tax abatement |
Pfizer, Inc. | Pfizer | Tennessee | local | 2013 | undisclosed | | property tax abatement |
Pfizer, Inc. | Pfizer | Tennessee | local | 2013 | undisclosed | | property tax abatement |
Pfizer, Inc. | Pfizer | Tennessee | local | 2013 | undisclosed | | property tax abatement |
JOHNSON & JOHNSON | Johnson & Johnson | Tennessee | local | 2013 | $11,559 | | property tax abatement |
JOHNSON & JOHNSON | Johnson & Johnson | Tennessee | local | 2013 | $11,337 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2013 | $2,584 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2013 | $4,837 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2013 | $45,482 | | property tax abatement |
PFIZER INC | Pfizer | Tennessee | local | 2013 | $12,319 | | property tax abatement |
PFIZER INC | Pfizer | Tennessee | local | 2013 | $15,136 | | property tax abatement |
JOHNSON & JOHNSON (UNDER MEMPHIS TRADE) | Johnson & Johnson | Tennessee | local | 2013 | $195,430 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE | Johnson & Johnson | Tennessee | local | 2013 | $61,809 | | property tax abatement |
ABBOTT MEDICAL OPTICS INC. | Abbott Laboratories | California | state | 2013 | $73,582 | | training reimbursement |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2013 | $514,750 | | property tax abatement |
Astellas US LLC | Astellas Pharma | United States | federal | 2013 | $1,160,482 | | federal grant |
Megadyne Medical Products, Inc. | Johnson & Johnson | United States | federal | 2013 | | $3,375,000 | federal loan or loan guarantee |
Blueprint Medicines Corp | Blueprint Medicines | Massachusetts | state | 2013 | $45,000 | | tax credit/rebate |
Moderna Therapeutics, Inc | Moderna Inc. | Massachusetts | state | 2013 | $147,996 | | tax credit/rebate |
Foundation Medicine, Inc. | Roche | Massachusetts | state | 2013 | $150,000 | | tax credit/rebate |
Aegerion Pharmaceuticals, Inc. | Amryt Pharma | Massachusetts | state | 2013 | $160,000 | | tax credit/rebate |
Moderna Therapeutics, Inc | Moderna Inc. | Massachusetts | state | 2013 | $170,504 | | tax credit/rebate |
Blueprint Medicines Corp | Blueprint Medicines | Massachusetts | state | 2013 | $200,000 | | tax credit/rebate |
Foundation Medicine, Inc. | Roche | Massachusetts | state | 2013 | $300,309 | | tax credit/rebate |
Epizyme, Inc. | Epizyme | Massachusetts | state | 2013 | $416,500 | | tax credit/rebate |
Merrimack Pharmaceuticals, Inc | Merrimack Pharmaceuticals | Massachusetts | state | 2013 | $490,000 | | tax credit/rebate |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2013 | $750,000 | | tax credit/rebate |
Synageva BioPharma Corp | AstraZeneca | Massachusetts | state | 2013 | $784,000 | | tax credit/rebate |
ARIAD Pharmaceuticals, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2013 | $1,225,000 | | tax credit/rebate |
PAREXEL International Corporation | Parexel International | Massachusetts | state | 2013 | $1,421,000 | | tax credit/rebate |
DePuy Orthopaedics, Inc. | Johnson & Johnson | Massachusetts | state | 2013 | $1,715,000 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | Massachusetts | state | 2013 | $5,512,500 | | tax credit/rebate |
Depuy Mitek, Inc. | Johnson & Johnson | Massachusetts | state | 2013 | $68,023 | | tax credit/rebate |
Codman & Shurtleff, Inc. | Johnson & Johnson | Massachusetts | state | 2013 | $115,391 | | tax credit/rebate |
Depuy Spine, Inc. | Johnson & Johnson | Massachusetts | state | 2013 | $43,223 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2013 | $1,441 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2013 | $3,605 | | tax credit/rebate |